Nasdaq · CIK 0001382101
STRO SUTRO BIOPHARMA, INC.
Insider trading from SEC Form 4. Last filing 20 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
17
with a Form 4 at this company
Signals
Open-market buys and sells at SUTRO BIOPHARMA, INC., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 13,712 | 20 d ago |
| Sep 18, 2026 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -1,345 | $15.34 | $21k | 12,367 | 20 d ago |
| Sep 18, 2026 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Restricted Stock Units (RSUs)derivative | -3,750 | $0.00 | $0 | 3,750 | 20 d ago |
| Sep 18, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Common Stock | +37,500 | $0.00 | $0 | 68,249 | Sep 22, 2025 |
| Sep 18, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -13,417 | $0.90 | $12k | 54,832 | Sep 22, 2025 |
| Sep 18, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Restricted Stock Units (RSUs)derivative | -37,500 | $0.00 | $0 | 75,000 | Sep 22, 2025 |
| Aug 9, 2025 | Jane Chung Chief Executive Officer | MOption exercise Common Stock | +18,750 | $0.00 | $0 | 117,058 | Aug 26, 2025 |
| Jul 8, 2025 | Barbara Leyman Chief Business Officer | MOption exercise Common Stock | +25,000 | $0.00 | $0 | 25,000 | Aug 26, 2025 |
| Jul 8, 2025 | Barbara Leyman Chief Business Officer | FTax withholding Common Stock | -8,944 | $0.78 | $6,976 | 16,056 | Aug 26, 2025 |
| Aug 9, 2025 | Jane Chung Chief Executive Officer | FTax withholding Common Stock | -6,708 | $0.80 | $5,366 | 110,350 | Aug 26, 2025 |
| Jul 8, 2025 | Barbara Leyman Chief Business Officer | MOption exercise Restricted Stock Units (RSUs)derivative | -25,000 | $0.00 | $0 | 75,000 | Aug 26, 2025 |
| Aug 9, 2025 | Jane Chung Chief Executive Officer | MOption exercise Restricted Stock Unit (RSU)derivative | -18,750 | $0.00 | $0 | 0 | Aug 26, 2025 |
| Jun 6, 2025 | Jon Marc Wigginton director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Joseph M Lobacki director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | James P Panek director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Connie Matsui director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Daniel H Petree director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Heidi Hunter director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Michael Dybbs director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 6, 2025 | Sukhi Jagpal director | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 10, 2025 |
| Jun 2, 2025 | Gregory K. Chow CFO | AGrant or award Stock Option (right to buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jun 2, 2025 |
| Jun 2, 2025 | Gregory K. Chow CFO | AGrant or award Restricted Stock Unit (RSU)derivative | +100,000 | $0.00 | $0 | 100,000 | Jun 2, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +24,438 | $0.00 | $0 | 156,519 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +11,156 | $0.00 | $0 | 167,675 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +9,125 | $0.00 | $0 | 176,800 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | FTax withholding Common Stock | -15,995 | $0.88 | $14k | 160,805 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -24,438 | $0.00 | $0 | 27,312 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -11,156 | $0.00 | $0 | 4,594 | May 19, 2025 |
| May 15, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -9,125 | $0.00 | $0 | 0 | May 19, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +9,125 | $0.00 | $0 | 104,558 | May 5, 2025 |
| May 1, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | MOption exercise Common Stock | +2,500 | $0.00 | $0 | 54,580 | May 5, 2025 |
| May 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Common Stock | +53,125 | $0.00 | $0 | 106,223 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +9,740 | $0.00 | $0 | 114,298 | May 5, 2025 |
| May 1, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | FTax withholding Common Stock | -894 | $1.07 | $957 | 53,686 | May 5, 2025 |
| May 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Common Stock | +15,938 | $0.00 | $0 | 122,161 | May 5, 2025 |
| May 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -24,709 | $1.07 | $26k | 97,452 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +13,140 | $0.00 | $0 | 127,438 | May 5, 2025 |
| May 1, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -2,500 | $0.00 | $0 | 5,000 | May 5, 2025 |
| May 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -53,125 | $0.00 | $0 | 21,875 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +5,844 | $0.00 | $0 | 133,282 | May 5, 2025 |
| May 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -15,938 | $0.00 | $0 | 17,812 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | FTax withholding Common Stock | -13,538 | $1.07 | $14k | 119,744 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -9,125 | $0.00 | $0 | 0 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -9,740 | $0.00 | $0 | 4,010 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -13,140 | $0.00 | $0 | 14,685 | May 5, 2025 |
| May 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -5,844 | $0.00 | $0 | 6,531 | May 5, 2025 |
| Apr 11, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | MOption exercise Common Stock | +21,250 | $0.00 | $0 | 59,683 | Apr 15, 2025 |
| Apr 11, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | FTax withholding Common Stock | -7,603 | $0.60 | $4,562 | 52,080 | Apr 15, 2025 |
| Apr 11, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -21,250 | $0.00 | $0 | 21,250 | Apr 15, 2025 |
| Apr 4, 2025 | Jane Chung Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +620,000 | $0.00 | $0 | 620,000 | Apr 8, 2025 |
| Apr 4, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +122,500 | $0.00 | $0 | 122,500 | Apr 8, 2025 |
| Apr 4, 2025 | Barbara Leyman Chief Business Dev. Officer | AGrant or award Stock Option (Right to Buy)derivative | +91,000 | $0.00 | $0 | 91,000 | Apr 8, 2025 |
| Apr 4, 2025 | David Pauling Chief Admin. Ofcr. & GC | AGrant or award Stock Option (Right to Buy)derivative | +101,500 | $0.00 | $0 | 101,500 | Apr 8, 2025 |
| Apr 4, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +101,500 | $0.00 | $0 | 101,500 | Apr 8, 2025 |
| Apr 4, 2025 | Jane Chung Chief Executive Officer | AGrant or award Restricted Stock Units (RSUs)derivative | +310,000 | $0.00 | $0 | 310,000 | Apr 8, 2025 |
| Apr 4, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | AGrant or award Restricted Stock Units (RSUs)derivative | +113,750 | $0.00 | $0 | 113,750 | Apr 8, 2025 |
| Apr 4, 2025 | Barbara Leyman Chief Business Dev. Officer | AGrant or award Restricted Stock Units (RSUs)derivative | +84,500 | $0.00 | $0 | 84,500 | Apr 8, 2025 |
| Apr 4, 2025 | David Pauling Chief Admin. Ofcr. & GC | AGrant or award Restricted Stock Units (RSUs)derivative | +94,250 | $0.00 | $0 | 94,250 | Apr 8, 2025 |
| Apr 4, 2025 | Venkatesh Srinivasan CHIEF TECH OP OFFICER | AGrant or award Restricted Stock Units (RSUs)derivative | +94,250 | $0.00 | $0 | 94,250 | Apr 8, 2025 |
| Mar 5, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +8,750 | $0.00 | $0 | 135,675 | Mar 7, 2025 |
| Mar 5, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +8,750 | $0.00 | $0 | 99,027 | Mar 7, 2025 |
| Mar 5, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | FTax withholding Common Stock | -3,594 | $1.36 | $4,888 | 95,433 | Mar 7, 2025 |
| Mar 5, 2025 | Edward C Albini CFO AND SECRETARY | FTax withholding Common Stock | -3,594 | $1.36 | $4,888 | 132,081 | Mar 7, 2025 |
| Mar 5, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -8,750 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Mar 5, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -8,750 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Mar 4, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +9,125 | $0.00 | $0 | 130,673 | Mar 6, 2025 |
| Mar 4, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Common Stock | +7,875 | $0.00 | $0 | 100,642 | Mar 6, 2025 |
| Mar 4, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +9,125 | $0.00 | $0 | 94,025 | Mar 6, 2025 |
| Mar 4, 2025 | Edward C Albini CFO AND SECRETARY | FTax withholding Common Stock | -3,748 | $1.42 | $5,322 | 126,925 | Mar 6, 2025 |
| Mar 4, 2025 | Jane Chung PRESIDENT AND COO | FTax withholding Common Stock | -2,334 | $1.42 | $3,314 | 98,308 | Mar 6, 2025 |
| Mar 4, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | FTax withholding Common Stock | -3,748 | $1.42 | $5,322 | 90,277 | Mar 6, 2025 |
| Mar 4, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -9,125 | $0.00 | $0 | 9,125 | Mar 6, 2025 |
| Mar 4, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Restricted Stock Unit (RSU)derivative | -7,875 | $0.00 | $0 | 7,875 | Mar 6, 2025 |
| Mar 4, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -9,125 | $0.00 | $0 | 9,125 | Mar 6, 2025 |
| Mar 1, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +7,875 | $0.00 | $0 | 114,618 | Mar 4, 2025 |
| Mar 1, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Common Stock | +6,875 | $0.00 | $0 | 77,217 | Mar 4, 2025 |
| Mar 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +6,875 | $0.00 | $0 | 79,827 | Mar 4, 2025 |
| Mar 1, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Common Stock | +11,250 | $0.00 | $0 | 35,370 | Mar 4, 2025 |
| Feb 28, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Common Stock | +37,500 | $0.00 | $0 | 61,874 | Mar 4, 2025 |
| Mar 1, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Common Stock | +17,250 | $0.00 | $0 | 131,868 | Mar 4, 2025 |
| Mar 1, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Common Stock | +25,000 | $0.00 | $0 | 102,217 | Mar 4, 2025 |
| Mar 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Common Stock | +13,400 | $0.00 | $0 | 93,227 | Mar 4, 2025 |
| Mar 1, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | FTax withholding Common Stock | -4,621 | $1.59 | $7,347 | 30,749 | Mar 4, 2025 |
| Feb 28, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -15,405 | $1.59 | $24k | 46,469 | Mar 4, 2025 |
| Mar 1, 2025 | Edward C Albini CFO AND SECRETARY | FTax withholding Common Stock | -10,320 | $1.59 | $16k | 121,548 | Mar 4, 2025 |
| Mar 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Common Stock | +11,250 | $0.00 | $0 | 57,719 | Mar 4, 2025 |
| Mar 1, 2025 | Jane Chung PRESIDENT AND COO | FTax withholding Common Stock | -9,450 | $1.59 | $15k | 92,767 | Mar 4, 2025 |
| Mar 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | FTax withholding Common Stock | -8,327 | $1.59 | $13k | 84,900 | Mar 4, 2025 |
| Mar 1, 2025 | Hans-Peter Gerber CHIEF SCIENTIFIC OFFICER | MOption exercise Restricted Stock Units (RSUs)derivative | -11,250 | $0.00 | $0 | 33,750 | Mar 4, 2025 |
| Mar 1, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -7,875 | $0.00 | $0 | 15,750 | Mar 4, 2025 |
| Mar 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | FTax withholding Common Stock | -4,621 | $1.59 | $7,347 | 53,098 | Mar 4, 2025 |
| Mar 1, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Restricted Stock Unit (RSU)derivative | -6,875 | $0.00 | $0 | 13,750 | Mar 4, 2025 |
| Mar 1, 2025 | Edward C Albini CFO AND SECRETARY | MOption exercise Restricted Stock Unit (RSU)derivative | -17,250 | $0.00 | $0 | 51,750 | Mar 4, 2025 |
| Mar 1, 2025 | Jane Chung PRESIDENT AND COO | MOption exercise Restricted Stock Unit (RSU)derivative | -25,000 | $0.00 | $0 | 75,000 | Mar 4, 2025 |
| Mar 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -6,875 | $0.00 | $0 | 13,750 | Mar 4, 2025 |
| Feb 28, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -37,500 | $0.00 | $0 | 75,000 | Mar 4, 2025 |
| Mar 1, 2025 | Anne Elizabeth Borgman CHIEF MEDICAL OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -11,250 | $0.00 | $0 | 33,750 | Mar 4, 2025 |
| Mar 1, 2025 | Linda A Fitzpatrick CHIEF PEOPLE & COMM. OFFICER | MOption exercise Restricted Stock Unit (RSU)derivative | -13,400 | $0.00 | $0 | 40,200 | Mar 4, 2025 |
| Dec 1, 2024 | Jane Chung PRESIDENT AND COO | MOption exercise Common Stock | +25,000 | $0.00 | $0 | 79,262 | Dec 3, 2024 |
| Dec 1, 2024 | Jane Chung PRESIDENT AND COO | FTax withholding Common Stock | -8,920 | $2.69 | $24k | 70,342 | Dec 3, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Edward C AlbiniCFO AND SECRETARY
- Anne Elizabeth BorgmanCHIEF MEDICAL OFFICER
- Gregory K. ChowCFO
- Jane ChungChief Executive Officer
- Michael Dybbsdirector
- Linda A FitzpatrickCHIEF PEOPLE & COMM. OFFICER
- Hans-Peter GerberCHIEF SCIENTIFIC OFFICER
- Heidi Hunterdirector
- Sukhi Jagpaldirector
- Barbara LeymanChief Business Officer
- Joseph M Lobackidirector
- Connie Matsuidirector
- James P Panekdirector
- David PaulingChief Admin. Ofcr. & GC
- Daniel H Petreedirector
- Venkatesh SrinivasanCHIEF TECH OP OFFICER
- Jon Marc Wiggintondirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.